Pfizer, Moderna Stocks Jump After FDA Allows Covid Boosters For All Adults

 Vaccine stocks popped Friday after the Food and Drug Administration authorized Covid boosters from Pfizer (PFE) and Moderna (MRNA) for all adults.

The move comes hours before advisors to the Centers for Disease Control and Prevention are set to meet to discuss the same topic. Previously, the FDA only allowed recipients of those vaccines to receive a booster if they were age 65 or older, at risk due to work or living exposure or immunocompromised.

Now, the FDA move allows any adult who completed their primary series six months ago can receive a booster shot from Pfizer and its partner BioNTech or Moderna. The FDA decision also allows for mixing and matching vaccines.

In premarket trading on the stock market today, vaccine stocks jumped. Moderna stock surged 4.8% near 263.50. Pfizer and BioNTech shares each rose more than 1% near 52.20 and 277.50, respectively.

https://www.investors.com/news/technology/vaccine-stocks-pop-as-fda-allows-pfizer-moderna-covid-boosters-for-all-adults/?src=A00220